| Literature DB >> 30909664 |
Sasivimon Ratree1, Pilaiwan Kleebkaow1, Apiwat Aue-Aungkul1, Amornrat Temtanakitpaisan1, Bandit Chumworathayi1, Sanguanchoke Luanratanakorn1.
Abstract
Objectives: To evaluate prevalence of underlying significant pathologies among women with cervical smears rated as ‘atypical squamous cells cannot exclude high grade squamous intraepithelial lesion (ASC-H)’, as well as associated risk factors.Entities:
Keywords: Atypical squamous cells; ASC-H; cervical intraepithelial neoplasia; cervical cancer
Mesh:
Year: 2019 PMID: 30909664 PMCID: PMC6825754 DOI: 10.31557/APJCP.2019.20.3.683
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Characteristics of 133 Women with ASC-H Smears
| Characteristics | Number (%) |
|---|---|
| Age (years) | |
| < 40 | 36 (27.1) |
| ≥ 40 | 97 (72.9) |
| Menopausal status | |
| Premenopause | 103 (77.4) |
| Postmenopause | 30 (22.6) |
| Parity status | |
| Nulliparity | 14 (10.5) |
| Multiparity | 119 (89.5) |
| Final histopathology results | |
| No lesions | 58 (43.6) |
| CIN 1 | 34 (25.6) |
| CIN 2-3 | 33 (24.8) |
| AIS | 2 (1.5) |
| Cervical cancer | 6 (4.5) |
ASC-H, atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions; CIN, cervical intraepithelial neoplasia; AIS, adenocarcinoma in situ.
Histopathology of 133 Women with ASC-H Stratified by Baseline Characteristics
| Characteristics | Proportion of women with significant lesions | Adjusted OR |
|---|---|---|
| Age (years) | ||
| <40 (n=36) | 15 (41.67) | 2.70 (1.11-6.56) |
| ≥40 (n=97) | 26 (26.80) | Reference category |
| Menopause status | ||
| Premenopause (n=103) | 29 (28.15) | 0.39 (0.15-1.01) |
| Postmenopause(n=30) | 12 (40.0) | Reference category |
| Parity | ||
| Nulliparous (n=14) | 4 (28.57) | 0.92 (0.27-3.13) |
| Multiparous (n=119) | 37 (31.09) | Reference category |
ASC-H, atypical squamous cells cannot exclude high-grade squamous intraepithelial lesions; OR, odds ratio; CI, confidence interval;
, Including cervical intraepithelial neoplasia 2-3 (33), adenocarcinoma in situ (2), and cervical cancer (6);
, Including patient’s age, menopausal status, and parity status in the model.
Rate of Significant Lesions Stratified by Patient Age in Previous Studies
| Authors | Year of publication | Age cut-off point (years) | Rate of significant lesions* |
|---|---|---|---|
| Kietpeerakool et al | 2008 | <40 | 71.50% |
| ≥40 | 68.80% | ||
| Bandyopadhyay et al | 2008 | <40 | 21.10% |
| ≥40 | 7.60% | ||
| Sung et al | 2011 | <40 | 52.30% |
| ≥40 | 27.80% | ||
| This study | 2017 | <40 | 41.70% |
| ≥40 | 25.80% | ||
| Lee et al | 2006 | < 50 | 38.80% |
| ≥50 | 30.00% | ||
| Cytryn et al | 2009 | < 50 | 22.20% |
| ≥50 | 8.30% | ||
| Selvaggi et al | 2013 | < 55 | 54.70% |
| ≥55 | 35.00% |